Apyx Medical vs IRIDEX
Apyx Medical reported revenue of $53 million in fiscal 2025, about the same as IRIDEX's $53 million in fiscal 2025. Apyx Medical's revenue grew 9.9% in its latest year, and IRIDEX's grew 8.2%. Apyx Medical had an operating margin of -12.2%, against -4.9% at IRIDEX. Free cash flow was −$9 million at Apyx Medical and −$2 million at IRIDEX. Their fiscal years end in different months (December 31 and January 3), so the periods don't line up exactly.
Side by side
| Apyx Medical | IRIDEX | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Jan 3, 2026 |
| Revenue | $53M | $53M |
| Revenue growth | 9.9% | 8.2% |
| Revenue growth a year, last 5 years | 13.8% | 7.7% |
| Gross margin | 62.5% | 36.5% |
| Operating margin | −12.2% | −4.9% |
| Net margin | −21.2% | −8.4% |
| Free cash flow | −$9M | −$2M |
| Free cash flow margin | −17.2% | −4.3% |
| Return on capital | −25.0% | — |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 15.6% | 3.0% |
| Last close | $2.39 | $0.47 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | — | — |
| Piotroski F-score | 4 of 9 | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Apyx MedicalIRIDEX
Operating margin
Percent of revenue
Apyx MedicalIRIDEX
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Apyx MedicalIRIDEX
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Apyx Medical and IRIDEX pages.